BeStock  
Stocks › Biotechnology › JANX

Janux Therapeutics JANX

US equityMarket cap rank #3470Biotechnology
$10.08 −$0.21 (-2.04%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $10.15 +0.69%
Open$10.11
Prev close$10.29
Day range$10.05 – $10.54
Volume1.11M
Market cap$616.73M
P/E (TTM)–
Dividend yield–

JANX Stock News

Headlines matching Janux Therapeutics or the JANX ticker, most recent first.

  • A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $60Market news · 8 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $55Market news · 7 Aug 2026 · Direct mention
  • Wolfe Research Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $23Market news · 24 Aug 2026 · Direct mention
  • William Blair Maintains Janux Therapeutics(JANX.US) With Buy RatingMarket news · 14 Aug 2026 · Direct mention
  • Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $35Market news · 13 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)TipRanks · 25 Jun 2026 · Direct mention
  • Truist Financial Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $26Market news · 25 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Janux Therapeutics Inc (JANX) and Progyny (PGNY)TipRanks · 8 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $58Market news · 8 May 2026 · Direct mention
  • Evercore Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $22 NegativeMarket news · 11 May 2026 · Direct mention
  • LifeSci Capital Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $60Market news · 10 May 2026 · Direct mention
  • JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $50Market news · 7 Apr 2026 · Direct mention
  • Guggenheim Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $68Market news · 29 Apr 2026 · Direct mention
  • A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $24 to $68Market news · 29 Apr 2026 · Direct mention
  • Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $38Market news · 28 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on JANX.

Sign in to join the discussion.

Scroll to Top